Free Trial

Genesco (GCO) Financials

Genesco logo
$37.35 +1.41 (+3.91%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Genesco

Annual Income Statements for Genesco

This table shows Genesco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
95 100 -112 -52 61 -56 115 72 -17 -19 13
Consolidated Net Income / (Loss)
95 97 -112 -52 61 -56 115 72 -17 -19 13
Net Income / (Loss) Continuing Operations
95 73 37 51 62 -56 115 72 -24 -20 13
Total Pre-Tax Income
152 113 69 78 82 -112 153 90 -22 9.31 13
Total Operating Income
151 108 74 82 83 -107 156 93 -13 14 17
Total Gross Profit
1,443 976 1,011 1,047 1,063 804 1,181 1,136 1,099 1,097 1,127
Total Revenue
3,022 2,021 2,128 2,189 2,197 1,787 2,422 2,385 2,325 2,325 2,436
Operating Revenue
3,022 2,021 2,128 2,189 2,197 1,787 2,422 2,385 2,325 2,325 2,436
Total Cost of Revenue
1,579 1,045 1,116 1,141 1,134 982 1,241 1,249 1,226 1,228 1,309
Operating Cost of Revenue
1,579 1,045 1,116 1,141 1,134 982 1,241 1,249 1,226 1,228 1,309
Total Operating Expenses
1,292 868 937 965 980 912 1,026 1,043 1,112 1,083 1,110
Selling, General & Admin Expense
1,284 876 929 962 966 814 1,034 1,042 1,082 1,080 1,101
Impairment Charge
7.90 -8.00 7.77 3.16 13 98 -8.06 0.86 30 3.24 8.07
Total Other Income / (Expense), net
0.28 7.37 -5.38 -3.56 -0.88 -4.42 -2.58 -3.17 -8.31 -4.62 -4.72
Interest Expense
4.41 5.29 5.42 3.94 1.28 5.09 2.45 2.92 7.78 4.25 4.10
Other Income / (Expense), net
4.69 13 0.03 0.38 0.40 0.67 -0.13 -0.25 -0.54 -0.37 -0.63
Income Tax Expense
56 40 32 27 21 -56 38 18 1.85 29 -0.69
Net Income / (Loss) Discontinued Operations
-0.80 25 -149 -103 -0.37 -0.40 -0.10 -0.33 6.80 0.62 -0.01
Basic Earnings per Share
$4.13 $4.85 ($5.82) ($2.68) $3.95 ($3.97) $8.11 $5.77 ($1.50) ($1.74) $1.28
Weighted Average Basic Shares Outstanding
21.31M 20.08M 19.22M 19.35M 15.54M 14.22M 14.17M 12.46M 11.24M 10.84M 10.37M
Diluted Earnings per Share
$4.11 $4.83 ($5.80) ($2.66) $3.92 ($3.97) $7.92 $5.66 ($1.50) ($1.74) $1.25
Weighted Average Diluted Shares Outstanding
21.31M 20.08M 19.28M 19.50M 15.67M 14.22M 14.51M 12.71M 11.24M 10.84M 10.62M
Weighted Average Basic & Diluted Shares Outstanding
21.31M 20.08M 3.73B 18.35M 14.69M 14.96M 13.66M 12.60M 11.48M 11.04M 10.86M

Quarterly Income Statements for Genesco

This table shows Genesco's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026 8/1/2026
Net Income / (Loss) Attributable to Common Shareholders
27 -24 -9.99 -19 34 -21 -18 5.36 48 -15 3.48
Consolidated Net Income / (Loss)
27 -24 -9.99 -19 34 -21 -18 5.36 48 -15 3.48
Net Income / (Loss) Continuing Operations
20 -24 -9.93 -19 34 -21 -18 5.42 48 -15 3.48
Total Pre-Tax Income
36 -33 -12 8.91 45 -30 -16 7.54 51 -16 3.40
Total Operating Income
37 -32 -10 10 46 -28 -14 8.58 51 -15 3.62
Total Gross Profit
342 216 246 285 350 221 250 289 367 229 272
Total Revenue
739 458 525 596 746 474 546 616 800 487 530
Operating Revenue
739 458 525 596 746 474 546 616 800 487 530
Total Cost of Revenue
397 241 280 311 396 253 296 328 433 258 258
Operating Cost of Revenue
397 241 280 311 396 253 296 328 433 258 258
Total Operating Expenses
305 248 256 275 304 249 264 280 316 244 269
Selling, General & Admin Expense
304 248 255 275 302 249 264 276 312 254 260
Impairment Charge
1.21 0.58 0.78 0.13 1.75 0.29 0.12 4.33 3.32 -10 8.94
Total Other Income / (Expense), net
-1.69 -1.00 -1.43 -1.30 -0.89 -1.52 -1.61 -1.03 -0.56 -0.50 -0.22
Interest Expense
1.54 0.89 1.35 1.21 0.80 1.34 1.46 0.88 0.42 0.27 -0.03
Other Income / (Expense), net
-0.15 -0.11 -0.09 -0.09 -0.09 -0.18 -0.15 -0.15 -0.15 -0.24 -0.25
Income Tax Expense
15 -8.84 -1.78 28 12 -8.45 2.41 2.12 3.24 -1.07 -0.08
Net Income / (Loss) Discontinued Operations
6.90 -0.06 -0.06 -0.08 0.83 -0.02 -0.02 -0.07 0.09 -0.01 -0.00
Basic Earnings per Share
$2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.52 $4.57 ($1.42) $0.33
Weighted Average Basic Shares Outstanding
11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.33M 10.37M 10.43M 10.54M
Diluted Earnings per Share
$2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.50 $4.56 ($1.42) $0.32
Weighted Average Diluted Shares Outstanding
11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.67M 10.62M 10.43M 10.92M
Weighted Average Basic & Diluted Shares Outstanding
11.48M 11.63M 11.22M 11.21M 11.04M 10.78M 10.80M 10.79M 10.86M 11.11M 10.82M

Annual Cash Flow Statements for Genesco

This table details how cash moves in and out of Genesco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Change in Cash & Equivalents
20 -85 -10 128 -86 134 105 -273 -13 -1.15 71
Net Cash From Operating Activities
150 165 165 237 117 158 240 -165 95 88 146
Net Cash From Continuing Operating Activities
150 165 165 237 117 158 240 -165 95 88 146
Net Income / (Loss) Continuing Operations
95 97 -112 -52 61 -56 115 72 -17 -19 13
Consolidated Net Income / (Loss)
95 97 -112 -52 61 -56 115 72 -17 -19 13
Depreciation Expense
79 76 78 77 50 46 43 43 49 52 53
Non-Cash Adjustments To Reconcile Net Income
18 10 202 155 26 111 -7.06 16 45 16 18
Changes in Operating Assets and Liabilities, net
-43 -19 -4.29 58 -20 57 89 -296 17 39 61
Net Cash From Investing Activities
-76 -71 -128 -57 53 -24 -34 -60 -60 -41 -62
Net Cash From Continuing Investing Activities
-76 -71 -128 -57 53 -24 -34 -60 -60 -41 -62
Purchase of Property, Plant & Equipment
-101 -94 -128 -57 -30 -24 -54 -60 -60 -41 -62
Acquisitions
-35 -0.02 0.00 -1.09 -34 0.00 -0.08 0.00 0.00 0.00 0.00
Divestitures
- - 0.25 0.31 116 0.11 20 0.00 0.09 0.00 0.00
Other Investing Activities, net
- 0.00 0.00 1.51 0.17 0.00 0.07 0.00 0.22 0.00 0.00
Net Cash From Financing Activities
-52 -178 -47 -53 -257 -3.16 -101 -46 -48 -47 -13
Net Cash From Continuing Financing Activities
-52 -178 -47 -53 -257 -3.16 -101 -46 -48 -47 -13
Repayment of Debt
-340 -376 -544 -305 -157 -222 -47 -303 -491 -457 -442
Repurchase of Common Equity
-142 -140 -16 -45 -190 -1.22 -82 -81 -34 -12 -14
Issuance of Debt
429 341 516 300 93 221 29 339 478 422 445
Other Financing Activities, net
0.79 -2.42 -3.15 -3.21 -2.36 -1.35 -1.28 -0.14 -0.01 0.00 -1.60
Effect of Exchange Rate Changes
-1.34 -1.08 - - 0.10 3.12 0.63 -2.19 -0.05 -0.90 1.01
Cash Interest Paid
3.41 4.26 5.35 3.34 3.01 4.39 2.33 2.74 7.84 4.48 4.35
Cash Income Taxes Paid
59 52 37 12 4.90 7.69 -0.18 51 5.89 3.51 -59

Quarterly Cash Flow Statements for Genesco

This table details how cash moves in and out of Genesco's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026 8/1/2026
Net Change in Cash & Equivalents
13 -16 27 -12 0.43 -12 19 -14 78 -78 30
Net Cash From Operating Activities
118 -34 28 -23 117 -101 86 -13 173 -103 76
Net Cash From Continuing Operating Activities
118 -34 28 -23 117 -101 86 -13 173 -103 76
Net Income / (Loss) Continuing Operations
27 -24 -9.99 -19 34 -21 -18 5.36 48 -15 3.48
Consolidated Net Income / (Loss)
27 -24 -9.99 -19 34 -21 -18 5.36 48 -15 3.48
Depreciation Expense
14 13 13 13 13 13 13 13 13 13 13
Non-Cash Adjustments To Reconcile Net Income
3.70 3.62 3.70 3.66 4.56 3.39 3.26 7.71 3.35 3.85 3.25
Changes in Operating Assets and Liabilities, net
73 -26 21 -21 65 -97 88 -39 109 -105 56
Net Cash From Investing Activities
-10 -6.38 -7.90 -13 -14 -19 -15 -19 -9.87 -15 -16
Net Cash From Continuing Investing Activities
-10 -6.38 -7.90 -13 -14 -19 -15 -19 -9.87 -15 -16
Purchase of Property, Plant & Equipment
-11 -6.38 -7.90 -13 -14 -19 -15 -19 -9.87 -15 -16
Net Cash From Financing Activities
-95 24 6.68 24 -102 107 -52 18 -86 40 -30
Net Cash From Continuing Financing Activities
-95 24 6.68 24 -102 107 -52 18 -86 40 -30
Repayment of Debt
-207 -58 -97 -123 -179 -68 -114 -115 -145 -10 -112
Repurchase of Common Equity
- 0.00 -11 -0.44 -0.50 -13 -0.50 -0.05 -0.11 -2.11 -0.46
Issuance of Debt
112 83 114 147 78 189 62 132 61 53 83
Other Financing Activities, net
- -0.77 - - - 0.00 - - -1.59 -0.14 0.02
Effect of Exchange Rate Changes
0.26 - - 0.30 -1.28 0.35 0.02 0.01 0.64 -0.11 -0.07
Cash Interest Paid
2.13 0.76 1.23 1.30 1.19 0.74 1.78 0.84 0.99 0.38 0.71
Cash Income Taxes Paid
0.40 1.12 0.47 0.69 1.23 0.39 -57 0.02 -2.58 0.22 -2.30

Annual Balance Sheets for Genesco

This table presents Genesco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Total Assets
1,541 1,441 1,315 1,181 1,680 1,587 1,562 1,456 1,330 1,336 1,393
Total Current Assets
800 717 693 731 508 668 710 573 507 609 619
Cash & Equivalents
133 48 40 167 81 215 321 48 35 34 105
Accounts Receivable
47 44 34 132 29 31 40 41 54 49 40
Inventories, net
530 564 388 367 365 291 278 458 379 425 434
Prepaid Expenses
61 61 54 65 32 130 72 26 40 101 39
Plant, Property, & Equipment, net
323 331 299 277 238 208 216 234 240 228 238
Total Noncurrent Assets
418 393 324 173 934 712 636 650 582 499 537
Goodwill
281 271 100 93 122 39 39 38 9.57 8.86 9.46
Intangible Assets
3.57 2.39 1.34 0.94 36 31 30 27 27 26 28
Noncurrent Deferred & Refundable Income Taxes
0.96 13 25 21 19 0.00 1.47 29 83 0.39 0.25
Other Noncurrent Operating Assets
132 106 58 57 756 642 566 556 462 463 499
Total Liabilities & Shareholders' Equity
1,541 1,441 1,315 1,181 1,680 1,587 1,562 1,456 1,330 1,336 1,393
Total Liabilities
584 518 485 444 1,061 1,021 960 849 759 789 826
Total Current Liabilities
324 309 255 276 362 403 432 361 320 380 376
Short-Term Debt
14 9.18 1.77 8.99 - - - - - - 0.00
Accounts Payable
154 171 123 159 136 150 152 145 115 168 157
Accrued Expenses
79 64 51 45 83 79 134 81 76 88 100
Other Current Liabilities
- - 1.90 0.55 143 174 145 134 129 124 119
Total Noncurrent Liabilities
261 209 230 167 699 618 528 489 439 409 450
Long-Term Debt
98 74 87 57 14 33 16 45 35 0.00 3.38
Other Noncurrent Operating Liabilities
- - 1.71 111 685 585 512 444 404 409 446
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
957 923 831 738 619 567 602 607 571 547 567
Total Preferred & Common Equity
955 921 829 738 619 567 602 607 571 547 567
Preferred Stock
1.08 1.06 1.05 1.06 1.01 1.01 0.83 0.82 0.81 0.84 0.84
Total Common Equity
954 920 828 736 618 566 602 606 570 546 566
Common Stock
246 258 271 284 289 298 306 318 331 344 355
Retained Earnings
768 731 604 509 379 321 350 347 297 266 266
Treasury Stock
-18 -18 -18 -18 -18 -18 -18 -18 -18 -18 -18
Accumulated Other Comprehensive Income / (Loss)
-43 -51 -29 -38 -32 -35 -36 -41 -40 -45 -37

Quarterly Balance Sheets for Genesco

This table presents Genesco's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 7/29/2023 10/28/2023 5/4/2024 8/3/2024 11/2/2024 5/3/2025 8/2/2025 11/1/2025 5/2/2026 8/1/2026
Total Assets
1,495 1,493 1,307 1,384 1,436 1,405 1,422 1,472 1,384 1,504
Total Current Assets
625 639 508 607 660 633 646 689 596 676
Cash & Equivalents
37 22 19 46 34 22 41 27 27 57
Accounts Receivable
50 57 50 57 52 53 54 56 48 40
Inventories, net
491 517 393 450 523 451 501 558 477 540
Prepaid Expenses
46 43 46 53 51 108 50 48 44 40
Plant, Property, & Equipment, net
244 245 234 229 230 237 239 241 240 242
Total Noncurrent Assets
626 609 566 548 546 534 537 542 549 586
Goodwill
9.72 9.28 9.42 9.28 9.23 9.32 9.34 9.18 9.48 9.19
Intangible Assets
28 26 27 27 27 28 27 27 28 27
Noncurrent Deferred & Refundable Income Taxes
86 33 26 25 59 0.39 0.39 0.39 0.25 0.25
Other Noncurrent Operating Assets
502 540 503 486 450 497 500 505 511 549
Total Liabilities & Shareholders' Equity
1,495 1,493 1,307 1,384 1,436 1,405 1,422 1,472 1,384 1,504
Total Liabilities
962 956 759 851 919 882 916 958 832 947
Total Current Liabilities
383 397 308 396 422 331 414 436 325 427
Short-Term Debt
- - 0.00 0.00 0.00 7.30 13 20 0.00 0.00
Accounts Payable
167 187 109 187 215 122 193 213 129 217
Accrued Expenses
79 76 74 86 84 75 85 83 80 101
Other Current Liabilities
137 135 125 123 123 127 123 120 116 109
Total Noncurrent Liabilities
579 559 451 455 497 551 501 522 507 521
Long-Term Debt
132 128 59 78 100 114 58 70 45 16
Other Noncurrent Operating Liabilities
448 431 391 378 396 438 444 453 461 505
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
533 537 548 533 517 522 506 514 552 557
Total Preferred & Common Equity
533 537 548 533 517 522 506 514 552 557
Preferred Stock
0.81 0.81 0.81 0.81 0.82 0.84 0.84 0.84 0.84 0.84
Total Common Equity
532 536 548 532 516 521 506 513 552 556
Common Stock
325 328 334 337 340 346 349 352 358 361
Retained Earnings
263 270 272 251 232 232 213 218 249 252
Treasury Stock
-18 -18 -18 -18 -18 -18 -18 -18 -18 -18
Accumulated Other Comprehensive Income / (Loss)
-38 -44 -41 -39 -39 -39 -38 -39 -37 -39

Annual Metrics And Ratios for Genesco

This table displays calculated financial ratios and metrics derived from Genesco's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
DEI Shares Outstanding
22,090,544.00 19,870,665.00 19,913,201.00 20,192,544.00 14,700,187.00 14,992,078.00 14,607,160.00 12,609,875.00 - - 10,792,736.00
DEI Adjusted Shares Outstanding
22,090,544.00 19,870,665.00 19,913,201.00 20,192,544.00 14,700,187.00 14,992,078.00 14,607,160.00 12,609,875.00 - - 10,792,736.00
DEI Earnings Per Adjusted Shares Outstanding
4.28 5.02 -5.62 -2.57 4.18 -3.76 7.86 5.70 - - 1.23
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.68% -33.13% 5.28% 2.87% 0.39% -18.69% 35.57% -1.54% -2.53% 0.02% 4.78%
EBITDA Growth
0.23% -16.44% -22.10% 3.69% -16.24% -145.08% 430.24% -31.55% -73.90% 86.27% 6.05%
EBIT Growth
-2.67% -22.78% -38.21% 10.48% 1.84% -227.31% 245.84% -40.17% -115.05% 196.86% 23.09%
NOPAT Growth
-10.08% -26.82% -43.20% 35.33% 16.55% -220.28% 255.69% -36.02% -112.60% -209.81% 162.54%
Net Income Growth
-3.23% 3.03% -214.79% 53.57% 218.21% -191.93% 303.53% -37.38% -123.40% -12.26% 170.24%
EPS Growth
-0.24% 17.52% -220.08% 54.14% 247.37% -201.28% 299.50% -28.54% -126.50% -16.00% 171.84%
Operating Cash Flow Growth
-21.13% 10.40% -0.40% 44.08% -50.59% 34.63% 52.07% -168.74% 157.49% -7.29% 65.85%
Free Cash Flow Firm Growth
-7.12% -21.26% 536.85% -87.22% 207.23% -36.60% 120.23% -213.49% 110.23% 20.66% 131.67%
Invested Capital Growth
2.26% 1.19% -34.53% 0.96% -13.15% -30.36% -22.63% 102.89% -5.48% -10.12% -9.35%
Revenue Q/Q Growth
1.33% -30.73% 5.73% 31.53% 0.10% -2.23% 3.90% -0.11% 0.60% 0.30% 2.27%
EBITDA Q/Q Growth
-4.25% -13.18% 445.20% -52.74% -8.32% 21.01% 11.42% -19.71% -21.23% 13.55% 8.08%
EBIT Q/Q Growth
-7.02% -19.03% 160.98% -68.05% -6.17% 13.97% 15.25% -26.51% -921.68% 189.08% 44.56%
NOPAT Q/Q Growth
-8.89% -26.58% 146.33% -76.69% 10.11% 13.86% -19.81% -22.95% -1,344.21% -914.47% 1,636.26%
Net Income Q/Q Growth
-5.71% 1.97% 7.83% -176.27% 260.91% 49.06% -19.48% -24.38% -232.09% 27.57% 33,923.08%
EPS Q/Q Growth
-3.97% 8.05% 9.52% -175.35% 349.68% 0.00% 0.00% -18.33% -102.70% 33.33% 933.33%
Operating Cash Flow Q/Q Growth
42.62% -26.04% 6.27% 0.73% -35.50% -4.78% -7.23% -5.55% 70.66% -1.50% 63.05%
Free Cash Flow Firm Q/Q Growth
127.79% -63.74% 645.91% -90.96% 55.61% -24.55% -2.08% -19.12% 186.23% -55.05% 1,001.58%
Invested Capital Q/Q Growth
-16.01% -9.74% -32.32% 0.18% -7.58% -0.80% -8.50% -2.07% -11.30% -12.08% -19.30%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.76% 48.29% 47.54% 47.84% 48.39% 45.03% 48.77% 47.64% 47.27% 47.17% 46.26%
EBITDA Margin
7.80% 9.75% 7.21% 7.27% 6.07% -3.36% 8.19% 5.69% 1.52% 2.84% 2.87%
Operating Margin
5.00% 5.33% 3.50% 3.74% 3.79% -6.00% 6.42% 3.91% -0.58% 0.60% 0.71%
EBIT Margin
5.16% 5.96% 3.50% 3.76% 3.81% -5.97% 6.42% 3.90% -0.60% 0.58% 0.69%
Profit (Net Income) Margin
3.13% 4.82% -5.26% -2.37% 2.79% -3.16% 4.74% 3.02% -0.72% -0.81% 0.54%
Tax Burden Percent
62.41% 86.41% -162.11% -66.36% 74.46% 50.53% 75.07% 79.84% 77.28% -202.94% 105.38%
Interest Burden Percent
97.18% 93.65% 92.73% 95.21% 98.47% 104.78% 98.43% 96.86% 155.56% 68.65% 75.44%
Effective Tax Rate
37.06% 35.36% 46.79% 34.55% 25.08% 0.00% 24.87% 19.80% 0.00% 309.63% -5.44%
Return on Invested Capital (ROIC)
10.12% 7.28% 4.97% 8.46% 10.51% -16.02% 34.26% 16.59% -1.60% -5.39% 3.73%
ROIC Less NNEP Spread (ROIC-NNEP)
11.82% 171.81% 192.90% 78.23% 11.73% -30.99% 35.10% 18.45% 409.21% -65.13% 11.07%
Return on Net Nonoperating Assets (RNNOA)
-0.45% 3.08% -17.73% -15.08% -1.46% 6.51% -14.62% -4.70% -1.25% 2.01% -1.35%
Return on Equity (ROE)
9.67% 10.37% -12.76% -6.62% 9.05% -9.52% 19.65% 11.89% -2.86% -3.38% 2.38%
Cash Return on Invested Capital (CROIC)
7.89% 6.10% 46.71% 7.51% 24.58% 19.76% 59.77% -51.35% 4.03% 5.27% 13.54%
Operating Return on Assets (OROA)
9.98% 8.08% 5.40% 6.59% 5.85% -6.52% 9.87% 6.16% -1.00% 1.02% 1.22%
Return on Assets (ROA)
6.05% 6.53% -8.12% -4.16% 4.29% -3.45% 7.29% 4.76% -1.21% -1.42% 0.97%
Return on Common Equity (ROCE)
9.64% 10.34% -12.72% -6.61% 9.03% -9.50% 19.61% 11.88% -2.85% -3.37% 2.38%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.95% -3.45% 0.00%
Net Operating Profit after Tax (NOPAT)
95 70 40 54 62 -75 117 75 -9.42 -29 18
NOPAT Margin
3.15% 3.45% 1.86% 2.45% 2.84% -4.20% 4.83% 3.14% -0.41% -1.26% 0.75%
Net Nonoperating Expense Percent (NNEP)
-1.70% -164.53% -187.93% -69.77% -1.23% 14.97% -0.83% -1.86% -410.82% 59.75% -7.33%
Return On Investment Capital (ROIC_SIMPLE)
8.91% 6.93% 4.31% 6.67% 9.85% -12.52% 18.91% 11.47% -1.56% -5.34% 3.20%
Cost of Revenue to Revenue
52.24% 51.71% 52.46% 52.16% 51.61% 54.97% 51.23% 52.36% 52.73% 52.83% 53.74%
SG&A Expenses to Revenue
42.50% 43.36% 43.68% 43.96% 43.99% 45.55% 42.68% 43.70% 46.55% 46.44% 45.21%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
42.76% 42.96% 44.04% 44.10% 44.60% 51.03% 42.34% 43.73% 47.85% 46.57% 45.55%
Earnings before Interest and Taxes (EBIT)
156 120 74 82 84 -107 155 93 -14 14 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
236 197 153 159 133 -60 198 136 35 66 70
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.53 1.28 0.80 1.24 0.93 1.03 1.53 0.99 0.58 0.86 0.55
Price to Tangible Book Value (P/TBV)
2.18 1.82 0.91 1.42 1.26 1.17 1.72 1.11 0.62 0.91 0.59
Price to Revenue (P/Rev)
0.48 0.58 0.31 0.42 0.26 0.33 0.38 0.25 0.14 0.20 0.13
Price to Earnings (P/E)
15.45 11.80 0.00 0.00 9.42 0.00 8.01 8.37 0.00 0.00 23.53
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.47% 8.47% 0.00% 0.00% 10.62% 0.00% 12.49% 11.94% 0.00% 0.00% 4.25%
Enterprise Value to Invested Capital (EV/IC)
1.52 1.26 1.13 1.27 0.93 1.04 2.07 0.99 0.58 0.85 0.45
Enterprise Value to Revenue (EV/Rev)
0.48 0.60 0.33 0.37 0.23 0.22 0.25 0.25 0.14 0.19 0.09
Enterprise Value to EBITDA (EV/EBITDA)
6.12 6.17 4.63 5.09 3.84 0.00 3.10 4.42 9.35 6.57 3.01
Enterprise Value to EBIT (EV/EBIT)
9.25 10.09 9.56 9.86 6.12 0.00 3.96 6.45 0.00 32.00 12.65
Enterprise Value to NOPAT (EV/NOPAT)
15.15 17.45 17.97 15.14 8.20 0.00 5.26 8.02 0.00 0.00 11.56
Enterprise Value to Operating Cash Flow (EV/OCF)
9.64 7.36 4.32 3.42 4.37 2.54 2.57 0.00 3.50 4.94 1.45
Enterprise Value to Free Cash Flow (EV/FCFF)
19.45 20.82 1.91 17.06 3.51 4.33 3.02 0.00 13.99 15.18 3.19
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.12 0.09 0.11 0.09 0.02 0.06 0.03 0.07 0.06 0.00 0.01
Long-Term Debt to Equity
0.10 0.08 0.10 0.08 0.02 0.06 0.03 0.07 0.06 0.00 0.01
Financial Leverage
-0.04 0.02 -0.09 -0.19 -0.12 -0.21 -0.42 -0.25 0.00 -0.03 -0.12
Leverage Ratio
1.60 1.59 1.57 1.59 2.11 2.76 2.69 2.50 2.37 2.38 2.45
Compound Leverage Factor
1.55 1.49 1.46 1.52 2.08 2.89 2.65 2.42 3.68 1.64 1.85
Debt to Total Capital
10.46% 8.25% 9.62% 8.18% 2.27% 5.50% 2.54% 6.88% 5.72% 0.00% 0.59%
Short-Term Debt to Total Capital
1.33% 0.91% 0.19% 1.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
9.13% 7.33% 9.42% 7.06% 2.27% 5.50% 2.54% 6.88% 5.72% 0.00% 0.59%
Preferred Equity to Total Capital
0.10% 0.11% 0.11% 0.13% 0.16% 0.17% 0.13% 0.13% 0.13% 0.15% 0.15%
Noncontrolling Interests to Total Capital
0.15% 0.15% 0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
89.29% 91.50% 90.10% 91.68% 97.57% 94.33% 97.33% 92.99% 94.14% 99.85% 99.26%
Debt to EBITDA
0.47 0.42 0.58 0.41 0.11 -0.55 0.08 0.33 0.98 0.00 0.05
Net Debt to EBITDA
-0.09 0.18 0.32 -0.64 -0.50 3.03 -1.54 -0.02 -0.01 0.00 -1.46
Long-Term Debt to EBITDA
0.41 0.37 0.56 0.36 0.11 -0.55 0.08 0.33 0.98 0.00 0.05
Debt to NOPAT
1.17 1.19 2.23 1.23 0.23 -0.44 0.13 0.60 -3.68 0.00 0.19
Net Debt to NOPAT
-0.23 0.50 1.22 -1.90 -1.07 2.43 -2.61 -0.04 0.05 0.00 -5.59
Long-Term Debt to NOPAT
1.03 1.06 2.19 1.06 0.23 -0.44 0.13 0.60 -3.68 0.00 0.19
Altman Z-Score
4.86 4.09 3.66 4.38 2.22 1.73 2.98 2.78 2.46 2.61 2.49
Noncontrolling Interest Sharing Ratio
0.30% 0.28% 0.29% 0.23% 0.15% 0.17% 0.16% 0.14% 0.14% 0.15% 0.15%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.47 2.32 2.72 2.65 1.40 1.66 1.64 1.59 1.59 1.60 1.64
Quick Ratio
0.56 0.30 0.29 1.09 0.31 0.61 0.83 0.25 0.28 0.22 0.39
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
74 58 372 48 146 93 204 -231 24 29 66
Operating Cash Flow to CapEx
367.42% 233.02% 128.73% 414.37% 393.62% 653.71% 444.99% -275.11% 157.20% 213.67% 234.89%
Free Cash Flow to Firm to Interest Expense
16.80 11.03 68.60 12.07 114.27 18.19 83.30 -79.26 3.05 6.72 16.15
Operating Cash Flow to Interest Expense
33.91 31.21 30.37 60.22 91.68 30.99 97.99 -56.47 12.19 20.68 35.57
Operating Cash Flow Less CapEx to Interest Expense
24.68 17.82 6.78 45.69 68.39 26.25 75.97 -76.99 4.44 11.00 20.43
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.93 1.36 1.54 1.75 1.54 1.09 1.54 1.58 1.67 1.74 1.79
Accounts Receivable Turnover
58.95 44.52 55.16 26.37 27.19 58.96 68.31 59.38 49.23 45.37 54.94
Inventory Turnover
2.80 1.91 2.34 3.02 3.10 2.99 4.36 3.39 2.93 3.05 3.05
Fixed Asset Turnover
9.61 6.18 6.76 7.60 8.52 8.01 11.42 10.60 9.81 9.93 10.46
Accounts Payable Turnover
9.55 6.43 7.59 8.10 7.70 6.86 8.19 8.40 9.44 8.69 8.06
Days Sales Outstanding (DSO)
6.19 8.20 6.62 13.84 13.42 6.19 5.34 6.15 7.41 8.04 6.64
Days Inventory Outstanding (DIO)
130.38 190.97 155.67 120.72 117.80 121.95 83.70 107.60 124.61 119.49 119.75
Days Payable Outstanding (DPO)
38.21 56.76 48.08 45.07 47.38 53.19 44.55 43.48 38.65 42.00 45.28
Cash Conversion Cycle (CCC)
98.36 142.41 114.21 89.49 83.84 74.95 44.50 70.27 93.37 85.53 81.12
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
951 962 630 636 552 385 298 604 571 513 465
Invested Capital Turnover
3.21 2.11 2.67 3.46 3.70 3.81 7.10 5.29 3.96 4.29 4.98
Increase / (Decrease) in Invested Capital
21 11 -332 6.02 -84 -168 -87 306 -33 -58 -48
Enterprise Value (EV)
1,442 1,215 711 811 512 401 615 600 331 434 211
Market Capitalization
1,461 1,178 660 911 578 582 919 602 331 467 312
Book Value per Share
$43.19 $46.30 $41.59 $36.47 $42.06 $37.74 $41.19 $48.07 $49.65 $48.71 $52.46
Tangible Book Value per Share
$30.29 $32.53 $36.48 $31.82 $31.28 $33.10 $36.50 $42.87 $46.44 $45.59 $49.00
Total Capital
1,069 1,005 919 803 634 600 618 652 606 547 570
Total Debt
112 83 88 66 14 33 16 45 35 0.00 3.38
Total Long-Term Debt
98 74 87 57 14 33 16 45 35 0.00 3.38
Net Debt
-22 35 48 -102 -67 -182 -305 -3.13 -0.47 -34 -102
Capital Expenditures (CapEx)
41 71 128 57 30 24 54 60 60 41 62
Debt-free, Cash-free Net Working Capital (DFCFNWC)
357 368 400 296 65 50 -42 164 153 195 137
Debt-free Net Working Capital (DFNWC)
491 417 440 464 146 265 278 212 188 229 242
Net Working Capital (NWC)
476 408 438 455 146 265 278 212 188 229 242
Net Nonoperating Expense (NNE)
0.63 -28 151 105 1.03 -19 2.03 2.87 7.41 -10 4.99
Net Nonoperating Obligations (NNO)
-5.90 40 -201 -102 -67 -182 -305 -3.13 -0.47 -34 -102
Total Depreciation and Amortization (D&A)
80 77 79 77 50 46 43 43 49 52 53
Debt-free, Cash-free Net Working Capital to Revenue
11.82% 18.23% 18.79% 13.55% 2.95% 2.77% -1.75% 6.87% 6.57% 8.39% 5.61%
Debt-free Net Working Capital to Revenue
16.23% 20.62% 20.67% 21.19% 6.66% 14.81% 11.48% 8.88% 8.08% 9.85% 9.94%
Net Working Capital to Revenue
15.77% 20.17% 20.59% 20.78% 6.66% 14.81% 11.48% 8.88% 8.08% 9.85% 9.94%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.13 $4.85 ($5.82) ($2.68) $3.95 ($3.97) $8.11 $5.77 ($1.50) ($1.74) $1.28
Adjusted Weighted Average Basic Shares Outstanding
21.31M 19.61M 19.92M 18.35M 15.54M 14.22M 14.17M 12.46M 11.24M 10.84M 10.37M
Adjusted Diluted Earnings per Share
$4.11 $4.83 ($5.82) ($2.66) $3.92 ($3.97) $7.92 $5.66 ($1.50) ($1.74) $1.25
Adjusted Weighted Average Diluted Shares Outstanding
21.31M 19.61M 19.92M 18.35M 15.67M 14.22M 14.51M 12.71M 11.24M 10.84M 10.62M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
21.31M 19.61M 19.92M 18.35M 14.69M 14.96M 13.66M 12.60M 11.48M 11.04M 10.86M
Normalized Net Operating Profit after Tax (NOPAT)
100 65 44 56 72 -6.52 111 75 12 12 18
Normalized NOPAT Margin
3.31% 3.19% 2.05% 2.54% 3.30% -0.36% 4.58% 3.16% 0.51% 0.52% 0.73%
Pre Tax Income Margin
5.01% 5.58% 3.24% 3.58% 3.75% -6.25% 6.32% 3.78% -0.94% 0.40% 0.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
35.33 22.74 13.73 20.87 65.50 -20.94 63.50 31.85 -1.80 3.19 4.07
NOPAT to Interest Expense
21.57 13.16 7.30 13.60 48.84 -14.75 47.75 25.61 -1.21 -6.87 4.45
EBIT Less CapEx to Interest Expense
26.10 9.35 -9.86 6.34 42.21 -25.68 41.48 11.32 -9.55 -6.49 -11.07
NOPAT Less CapEx to Interest Expense
12.34 -0.24 -16.29 -0.93 25.55 -19.49 25.73 5.09 -8.97 -16.55 -10.69
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
150.21% 144.20% -14.45% -86.53% 310.15% -2.17% 71.52% 113.21% -203.70% -65.44% 104.63%

Quarterly Metrics And Ratios for Genesco

This table displays calculated financial ratios and metrics derived from Genesco's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026 8/1/2026
DEI Shares Outstanding
- - - - - 11,038,311.00 10,778,805.00 10,795,425.00 10,792,736.00 10,858,224.00 11,106,973.00
DEI Adjusted Shares Outstanding
- - - - - 11,038,311.00 10,778,805.00 10,795,425.00 10,792,736.00 10,858,224.00 11,106,973.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -1.92 -1.71 0.50 4.41 -1.36 0.31
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.92% -5.32% 0.41% 2.94% 0.95% 3.58% 3.96% 3.34% 7.24% 2.75% -2.95%
EBITDA Growth
-15.73% -60.98% 110.43% 0.63% 15.40% 21.41% -139.66% -6.00% 8.87% 84.15% 1,585.91%
EBIT Growth
-25.36% -39.62% 73.28% -5.42% 23.86% 12.14% -40.81% -16.76% 11.18% 44.88% 123.10%
NOPAT Growth
-47.27% -39.71% 73.40% -356.63% 61.00% 12.40% -40.55% 128.55% 40.45% 45.37% 136.67%
Net Income Growth
-30.19% -28.89% 68.44% -389.52% 26.45% 12.81% -84.86% 128.29% 38.48% 30.21% 118.83%
EPS Growth
-24.92% -39.38% 67.38% -393.33% 37.99% 9.42% -96.70% 128.41% 44.30% 29.70% 117.88%
Operating Cash Flow Growth
49.63% 44.17% -21.51% -1,546.96% -1.13% -199.42% 211.54% 44.09% 48.18% -1.72% -11.54%
Free Cash Flow Firm Growth
120.44% 121.37% 161.69% 308.70% 69.22% -190.87% -67.18% -65.20% 4.37% 176.27% 34.35%
Invested Capital Growth
-5.48% -12.01% -9.97% -9.32% -10.12% 5.58% -5.01% -1.23% -9.35% -8.18% -3.86%
Revenue Q/Q Growth
27.56% -38.07% 14.77% 13.55% 25.09% -36.46% 15.19% 12.87% 29.81% -39.12% 8.79%
EBITDA Q/Q Growth
122.08% -137.14% 114.78% 725.13% 154.70% -125.29% 92.54% 2,055.83% 194.99% -103.68% 799.32%
EBIT Q/Q Growth
247.19% -186.74% 67.86% 197.72% 354.67% -161.53% 48.50% 157.77% 507.27% -130.51% 121.58%
NOPAT Q/Q Growth
152.52% -205.84% 68.02% -200.28% 258.42% -157.59% 48.69% 160.99% 679.46% -122.40% 134.43%
Net Income Q/Q Growth
315.80% -189.55% 58.96% -89.47% 281.60% -161.74% 12.98% 129.00% 788.93% -131.11% 123.48%
EPS Q/Q Growth
281.67% -197.38% 59.19% -93.41% 279.55% -163.92% 11.39% 127.93% 812.00% -131.14% 122.54%
Operating Cash Flow Q/Q Growth
7,319.19% -128.52% 182.13% -183.27% 606.93% -186.36% 185.46% -114.95% 1,443.44% -159.28% 174.32%
Free Cash Flow Firm Q/Q Growth
395.46% 6.43% -4.32% -30.63% 139.56% -157.15% 134.55% -26.43% 618.39% -58.24% -39.14%
Invested Capital Q/Q Growth
-11.30% 3.14% -4.08% 3.34% -12.08% 21.16% -13.71% 7.44% -19.30% 22.72% -9.64%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
46.29% 47.26% 46.77% 47.84% 46.87% 46.67% 45.78% 46.84% 45.89% 47.00% 51.36%
EBITDA Margin
6.92% -4.15% 0.53% 3.89% 7.91% -3.15% -0.20% 3.54% 8.03% -0.49% 3.12%
Operating Margin
5.05% -7.02% -1.96% 1.71% 6.18% -5.94% -2.64% 1.39% 6.42% -3.16% 0.68%
EBIT Margin
5.03% -7.04% -1.97% 1.70% 6.17% -5.98% -2.67% 1.37% 6.40% -3.21% 0.64%
Profit (Net Income) Margin
3.68% -5.32% -1.90% -3.17% 4.61% -4.48% -3.38% 0.87% 5.95% -3.04% 0.66%
Tax Burden Percent
76.32% 73.50% 85.37% -212.46% 76.02% 71.56% 115.11% 71.01% 93.80% 93.29% 102.38%
Interest Burden Percent
95.87% 102.76% 112.98% 88.02% 98.26% 104.73% 110.00% 89.51% 99.19% 101.70% 100.83%
Effective Tax Rate
43.05% 0.00% 0.00% 311.51% 25.82% 0.00% 0.00% 28.12% 6.38% 0.00% -2.47%
Return on Invested Capital (ROIC)
11.38% -17.97% -5.29% -13.68% 19.68% -16.08% -7.94% 4.11% 29.92% -9.08% 3.24%
ROIC Less NNEP Spread (ROIC-NNEP)
-318.12% -20.90% -9.73% -10.61% 18.70% -18.27% -34.95% 2.86% 30.57% -15.97% 7.24%
Return on Net Nonoperating Assets (RNNOA)
0.97% -2.34% -1.15% -1.74% -0.58% -2.38% -2.08% 0.36% -3.73% -1.75% -0.08%
Return on Equity (ROE)
12.36% -20.31% -6.44% -15.43% 19.10% -18.47% -10.03% 4.47% 26.19% -10.83% 3.16%
Cash Return on Invested Capital (CROIC)
4.03% 10.26% 11.17% 10.36% 5.27% -9.24% -2.26% 1.04% 13.54% 12.30% 12.25%
Operating Return on Assets (OROA)
8.39% -11.56% -3.15% 2.69% 10.77% -10.32% -4.50% 2.24% 11.42% -5.63% 1.06%
Return on Assets (ROA)
6.14% -8.73% -3.04% -5.03% 8.04% -7.73% -5.70% 1.42% 10.63% -5.34% 1.09%
Return on Common Equity (ROCE)
12.34% -20.28% -6.43% -15.40% 19.08% -18.44% -10.01% 4.46% 26.15% -10.81% 3.15%
Return on Equity Simple (ROE_SIMPLE)
0.00% -4.06% -0.11% -5.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
21 -22 -7.19 -22 34 -20 -10 6.16 48 -11 3.71
NOPAT Margin
2.88% -4.91% -1.37% -3.62% 4.59% -4.16% -1.85% 1.00% 6.01% -2.21% 0.70%
Net Nonoperating Expense Percent (NNEP)
329.51% 2.94% 4.44% -3.08% 0.98% 2.19% 27.00% 1.25% -0.65% 6.89% -4.00%
Return On Investment Capital (ROIC_SIMPLE)
3.51% -3.70% -1.18% -3.50% 6.25% -3.06% -1.75% 1.02% 8.42% -1.80% 0.65%
Cost of Revenue to Revenue
53.71% 52.74% 53.23% 52.16% 53.13% 53.33% 54.22% 53.16% 54.11% 53.00% 48.64%
SG&A Expenses to Revenue
41.08% 54.16% 48.58% 46.10% 40.46% 52.54% 48.40% 44.74% 39.06% 52.24% 48.99%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
41.24% 54.29% 48.73% 46.12% 40.69% 52.60% 48.43% 45.45% 39.47% 50.16% 50.67%
Earnings before Interest and Taxes (EBIT)
37 -32 -10 10 46 -28 -15 8.43 51 -16 3.37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
51 -19 2.81 23 59 -15 -1.11 22 64 -2.37 17
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.58 0.51 0.60 0.54 0.86 0.43 0.50 0.61 0.55 0.69 0.76
Price to Tangible Book Value (P/TBV)
0.62 0.55 0.65 0.58 0.91 0.47 0.54 0.66 0.59 0.74 0.82
Price to Revenue (P/Rev)
0.14 0.12 0.14 0.12 0.20 0.10 0.11 0.13 0.13 0.15 0.17
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 8,030.14 23.53 19.22 10.20
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 4.25% 5.20% 9.81%
Enterprise Value to Invested Capital (EV/IC)
0.58 0.55 0.63 0.59 0.85 0.52 0.53 0.65 0.45 0.70 0.74
Enterprise Value to Revenue (EV/Rev)
0.14 0.14 0.15 0.15 0.19 0.14 0.12 0.16 0.09 0.16 0.16
Enterprise Value to EBITDA (EV/EBITDA)
9.35 11.38 6.09 5.97 6.57 4.65 4.32 5.81 3.01 4.81 3.83
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 67.05 73.99 32.00 18.64 21.57 32.61 12.65 13.52 8.11
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 87.60 96.82 0.00 0.00 0.00 0.00 11.56 17.70 8.78
Enterprise Value to Operating Cash Flow (EV/OCF)
3.50 2.65 3.10 3.89 4.94 15.81 3.61 4.21 1.45 2.76 2.86
Enterprise Value to Free Cash Flow (EV/FCFF)
13.99 4.98 5.31 5.46 15.18 0.00 0.00 62.65 3.19 5.42 5.96
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.06 0.11 0.15 0.19 0.00 0.23 0.14 0.17 0.01 0.08 0.03
Long-Term Debt to Equity
0.06 0.11 0.15 0.19 0.00 0.22 0.11 0.14 0.01 0.08 0.03
Financial Leverage
0.00 0.11 0.12 0.16 -0.03 0.13 0.06 0.13 -0.12 0.11 -0.01
Leverage Ratio
2.37 2.48 2.70 2.78 2.38 2.53 2.70 2.82 2.45 2.59 2.75
Compound Leverage Factor
2.27 2.55 3.05 2.45 2.34 2.65 2.97 2.53 2.43 2.64 2.77
Debt to Total Capital
5.72% 9.78% 12.75% 16.23% 0.00% 18.82% 12.29% 14.84% 0.59% 7.59% 2.76%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 1.13% 2.30% 3.27% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
5.72% 9.78% 12.75% 16.23% 0.00% 17.68% 9.99% 11.57% 0.59% 7.59% 2.76%
Preferred Equity to Total Capital
0.13% 0.13% 0.13% 0.13% 0.15% 0.13% 0.14% 0.14% 0.15% 0.14% 0.15%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
94.14% 90.09% 87.12% 83.64% 99.85% 81.05% 87.57% 85.03% 99.26% 92.27% 97.10%
Debt to EBITDA
0.98 2.10 1.34 1.72 0.00 1.73 1.07 1.38 0.05 0.55 0.16
Net Debt to EBITDA
-0.01 1.42 0.55 1.14 0.00 1.42 0.45 0.96 -1.46 0.22 -0.41
Long-Term Debt to EBITDA
0.98 2.10 1.34 1.72 0.00 1.62 0.87 1.08 0.05 0.55 0.16
Debt to NOPAT
-3.68 -3.76 19.30 27.93 0.00 -5.25 -1.74 -75.32 0.19 2.02 0.36
Net Debt to NOPAT
0.05 -2.54 7.93 18.56 0.00 -4.31 -0.74 -52.57 -5.59 0.81 -0.95
Long-Term Debt to NOPAT
-3.68 -3.76 19.30 27.93 0.00 -4.93 -1.42 -58.72 0.19 2.02 0.36
Altman Z-Score
2.58 2.37 2.30 2.25 2.69 2.24 2.20 2.25 2.57 2.49 2.33
Noncontrolling Interest Sharing Ratio
0.14% 0.14% 0.15% 0.16% 0.15% 0.15% 0.16% 0.16% 0.15% 0.16% 0.16%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.59 1.65 1.53 1.56 1.60 1.91 1.56 1.58 1.64 1.83 1.58
Quick Ratio
0.28 0.23 0.26 0.20 0.22 0.23 0.23 0.19 0.39 0.23 0.23
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
54 58 55 38 92 -53 18 13 96 40 24
Operating Cash Flow to CapEx
1,120.08% -529.15% 350.96% -175.87% 851.79% -534.64% 588.09% -69.36% 1,756.58% -666.66% 467.78%
Free Cash Flow to Firm to Interest Expense
35.39 65.00 41.15 31.65 114.69 -39.26 12.45 15.12 230.76 151.29 0.00
Operating Cash Flow to Interest Expense
77.04 -37.91 20.61 -19.03 145.88 -75.46 59.18 -14.60 416.72 -387.82 0.00
Operating Cash Flow Less CapEx to Interest Expense
70.16 -45.08 14.73 -29.85 128.75 -89.57 49.12 -35.64 393.00 -445.99 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.67 1.64 1.60 1.58 1.74 1.73 1.68 1.64 1.79 1.76 1.66
Accounts Receivable Turnover
49.23 44.13 42.67 42.41 45.37 45.49 42.25 44.03 54.94 48.73 51.75
Inventory Turnover
2.93 2.81 2.59 2.36 3.05 2.94 2.64 2.35 3.05 2.83 2.45
Fixed Asset Turnover
9.81 9.73 9.73 9.76 9.93 9.95 10.10 10.11 10.46 10.28 10.12
Accounts Payable Turnover
9.44 9.60 6.89 6.12 8.69 10.73 6.60 5.95 8.06 10.47 6.23
Days Sales Outstanding (DSO)
7.41 8.27 8.55 8.61 8.04 8.02 8.64 8.29 6.64 7.49 7.05
Days Inventory Outstanding (DIO)
124.61 129.95 140.97 154.44 119.49 124.17 138.19 155.04 119.75 128.79 148.81
Days Payable Outstanding (DPO)
38.65 38.03 53.01 59.65 42.00 34.01 55.27 61.32 45.28 34.87 58.59
Cash Conversion Cycle (CCC)
93.37 100.19 96.52 103.40 85.53 98.19 91.56 102.01 81.12 101.41 97.27
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
571 589 565 583 513 622 536 576 465 571 516
Invested Capital Turnover
3.96 3.66 3.86 3.78 4.29 3.87 4.29 4.11 4.98 4.11 4.63
Increase / (Decrease) in Invested Capital
-33 -80 -63 -60 -58 33 -28 -7.20 -48 -51 -21
Enterprise Value (EV)
331 321 353 347 434 326 286 376 211 397 384
Market Capitalization
331 280 321 280 467 226 255 313 312 378 425
Book Value per Share
$49.65 $47.72 $45.74 $45.99 $48.71 $47.24 $46.90 $47.51 $52.46 $50.80 $50.07
Tangible Book Value per Share
$46.44 $44.55 $42.61 $42.74 $45.59 $43.90 $43.49 $44.16 $49.00 $47.39 $46.80
Total Capital
606 608 610 617 547 643 577 603 570 598 573
Total Debt
35 59 78 100 0.00 121 71 90 3.38 45 16
Total Long-Term Debt
35 59 78 100 0.00 114 58 70 3.38 45 16
Net Debt
-0.47 40 32 67 -34 99 30 62 -102 18 -41
Capital Expenditures (CapEx)
11 6.38 7.90 13 14 19 15 19 9.87 15 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
153 181 165 204 195 288 204 246 137 244 192
Debt-free Net Working Capital (DFNWC)
188 200 211 238 229 310 245 273 242 271 250
Net Working Capital (NWC)
188 200 211 238 229 302 232 253 242 271 250
Net Nonoperating Expense (NNE)
-5.94 1.86 2.80 -2.66 -0.17 1.53 8.36 0.81 0.44 4.05 0.23
Net Nonoperating Obligations (NNO)
-0.47 40 32 67 -34 99 30 62 -102 18 -41
Total Depreciation and Amortization (D&A)
14 13 13 13 13 13 13 13 13 13 13
Debt-free, Cash-free Net Working Capital to Revenue
6.57% 7.86% 7.18% 8.80% 8.39% 12.30% 8.63% 10.32% 5.61% 9.95% 7.91%
Debt-free Net Working Capital to Revenue
8.08% 8.69% 9.17% 10.25% 9.85% 13.23% 10.36% 11.46% 9.94% 11.06% 10.26%
Net Working Capital to Revenue
8.08% 8.69% 9.17% 10.25% 9.85% 12.91% 9.80% 10.63% 9.94% 11.06% 10.26%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.52 $4.57 ($1.42) $0.33
Adjusted Weighted Average Basic Shares Outstanding
11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.33M 10.37M 10.43M 10.54M
Adjusted Diluted Earnings per Share
$2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.50 $4.56 ($1.42) $0.32
Adjusted Weighted Average Diluted Shares Outstanding
11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.67M 10.62M 10.43M 10.92M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
11.48M 11.63M 11.22M 11.21M 11.04M 10.78M 10.80M 10.79M 10.86M 11.11M 10.82M
Normalized Net Operating Profit after Tax (NOPAT)
22 -22 -6.65 7.24 36 -19 -10 9.28 51 -18 8.79
Normalized NOPAT Margin
2.97% -4.83% -1.27% 1.21% 4.76% -4.11% -1.84% 1.51% 6.40% -3.66% 1.66%
Pre Tax Income Margin
4.82% -7.24% -2.23% 1.49% 6.06% -6.26% -2.94% 1.22% 6.35% -3.26% 0.64%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
24.19 -36.22 -7.70 8.35 57.40 -21.15 -10.00 9.53 123.02 -58.92 0.00
NOPAT to Interest Expense
13.83 -25.27 -5.35 -17.80 42.66 -14.71 -6.93 6.97 115.50 -40.62 0.00
EBIT Less CapEx to Interest Expense
17.32 -43.39 -13.57 -2.47 40.27 -35.27 -20.06 -11.51 99.29 -117.09 0.00
NOPAT Less CapEx to Interest Expense
6.96 -32.43 -11.22 -28.62 25.53 -28.83 -16.99 -14.07 91.78 -98.79 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-203.70% -110.65% -1,876.76% -45.48% -65.44% -162.28% -60.47% 36,589.74% 104.63% 14.02% 6.53%

Financials Breakdown Chart

Key Financial Trends

Genesco’s recent results show improving profitability, but sales remain uneven and inventory is elevated. In Q2 fiscal 2027, revenue was $529.9 million, down 3.0% from $546.0 million in Q2 fiscal 2026 but slightly above $525.2 million in Q2 fiscal 2025. The company’s gross margin improved substantially to approximately 51.4%, compared with 45.8% a year earlier, helping Genesco produce operating income of $3.6 million versus a $14.4 million operating loss in the prior-year quarter.

Profitability has also improved sequentially. Q1 fiscal 2027 produced a $14.8 million net loss, while Q2 generated net income of $3.5 million, or $0.32 per diluted share. However, the improvement follows a strong Q4 fiscal 2026, when Genesco earned $47.6 million, so results remain highly seasonal and dependent on second-half sales.

  • Gross-margin recovery: Q2 fiscal 2027 gross profit increased to $272.1 million despite lower revenue, lifting the gross margin by roughly 560 basis points year over year.
  • Return to quarterly profitability: Genesco moved from a $14.8 million net loss in Q1 fiscal 2027 to $3.5 million of net income in Q2. Operating income also improved from a $15.4 million loss in Q1 to a $3.6 million profit.
  • Strong operating cash flow in Q2: Cash flow from operations was $76.4 million in Q2 fiscal 2027, providing funding for capital expenditures and reducing reliance on external financing during the quarter.
  • Lower reported debt balance: At the end of Q2 fiscal 2027, Genesco had no short-term debt and $15.8 million of long-term debt, down from $45.3 million of long-term debt at the end of Q1 and $69.8 million at the end of Q3 fiscal 2026.
  • Improved liquidity: Cash and equivalents rose to $57.1 million from $27.1 million in Q1 fiscal 2027. Total current assets of $676.3 million exceeded current liabilities of $426.8 million, producing a current ratio of approximately 1.6.
  • Seasonal earnings pattern: Recent results show significant volatility by quarter, with losses in the first quarter, near break-even results in the second quarter and much stronger profitability in the fourth quarter. Investors should place greater emphasis on full-year results and holiday-season execution.
  • Capital spending remains consistent: Genesco spent $16.3 million on property, plant and equipment in Q2 fiscal 2027, broadly in line with spending in recent quarters. This suggests continued investment in stores, technology or other operating assets, although the data does not identify the specific projects.
  • Revenue growth has not yet become consistent: Q2 fiscal 2027 revenue declined year over year, following a 2.8% increase in Q1. The company’s sales remain below the $616.2 million recorded in Q3 fiscal 2026 and are well below the $799.9 million reported in Q4 fiscal 2026, reflecting substantial seasonality and possible demand pressure.
  • Inventory is a major working-capital risk: Inventory reached $539.7 million at the end of Q2 fiscal 2027, up from $501.0 million a year earlier and representing roughly 80% of current assets. Elevated inventory can lead to markdowns, weaker margins and additional cash usage if merchandise does not sell as planned.
  • Cash generation remains uneven and financing-dependent: Operating cash flow was negative $102.8 million in Q1 fiscal 2027 before turning positive in Q2. Genesco also issued $82.9 million of debt while repaying $112.4 million during Q2, indicating ongoing refinancing and seasonal funding needs despite the lower ending debt balance.

Overall, Genesco’s improving gross margin, positive second-quarter earnings and stronger cash balance are encouraging. The main risks are inconsistent revenue, high inventory levels and volatile seasonal cash flow. Sustained improvement would require the margin recovery to continue while the company converts inventory into cash without significant markdowns.

10/15/26 01:00 PM ETAI Generated. May Contain Errors.

Genesco Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Genesco's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Genesco's net income appears to be on a downward trend, with a most recent value of $13.27 million in 2026, falling from $94.57 million in 2016. The previous period was -$18.89 million in 2025. View Genesco's forecast to see where analysts expect Genesco to go next.

Genesco's total operating income in 2026 was $17.31 million, based on the following breakdown:
  • Total Gross Profit: $1.13 billion
  • Total Operating Expenses: $1.11 billion

Over the last 10 years, Genesco's total revenue changed from $3.02 billion in 2016 to $2.44 billion in 2026, a change of -19.4%.

In the past 12 quarters, Genesco's cash and equivalents has ranged from $19.25 million in Q1 2025 to $57.13 million in Q2 2027, and is currently $57.13 million as of their latest financial filing in Q2 2027.

Genesco had total debt of $3.38 million at the end of 2026, compared with none in 2025, and a 97.0% decrease since 2016.

Over the last 10 years, Genesco's book value per share changed from 43.19 in 2016 to 52.46 in 2026, a change of 21.5%.



Financial statements for NYSE:GCO last updated on 9/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners